Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

Coronary Artery Disease

Volumn 22, Issue 6, 2011, Pages 405-410

  Seo, Suk Min ^a   Kim, Seonghun ^d   Chang, Kiyuk ^b   Min, Jinsoo ^b   Kim, Tae Hoon ^b   Koh, Yoon Seok ^c   Park, Hun Jun ^d   Shin, Woo Seung ^c   Lee, Jong Min ^c   Kim, Pum Joon ^b   Chung, Wook Sung ^b   Seung, Ki Bae ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Uijeongbu St Mary's Hospital   (South Korea)

^d Cheongju Hana General Hospital   (South Korea)

Author keywords

B type natriuretic peptide; myocardial tissue perfusion; primary percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; PLASMA B TYPE NATRIURETIC PEPTIDE; STATIN; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 80051786838     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283487dac     Document Type: Article

References (34)

1. The GUSTO Angiographic Investigators. The effects of tissue activator, streptokinase, or both on coronary artery patency, plasminogen ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-1622.
2. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36:1202-1209.
3. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002;39:591-597. (Pubitemid 34158153)
4. Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction. An ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004;44:335-339. (Pubitemid 38950592)
5. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001;37:386-391.
6. Antman EM, Ande DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation 2004;110:588-636.
7. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet 2006;367:579-588. (Pubitemid 43247573)
8. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001;37:386-391.
9. TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 1998;312:932-936.
10. Schroder R, Wegscheider K, Schroder K, Dissmann R, Meyer-Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. J Am Coll Cardiol 1995;26:1657-1664.
11. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888. (Pubitemid 26074824)
12. Van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, De Boer MJ, Zijlstra F Z wolle Myocardial Infarction Study Group. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 1998;97:2302-2306. (Pubitemid 28280383)
13. De Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 2001;38:1283-1294. (Pubitemid 33032999)
14. Brener SJ, Moliterno DJ, Aylward PE, Van't Hof AW, Ruźyllo W, O'Neill WW, et al. Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study. Eur Heart J 2008;29:1127-1135. (Pubitemid 351844887)
15. Roe MT, Ohman EM, Maas AC, Christenson RH, Mahaffey KW, Granger CB, et al. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol 2001;37:9-18. (Pubitemid 32051713)
16. Kunichika H, Ben-Yehuda O, Lafitte S, Kunichika N, Peters B, DeMaria AN. Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study. J Am Coll Cardiol 2004;43:276-283. (Pubitemid 38201156)
17. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993;88:82-91. (Pubitemid 23195436)
18. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 2000;23:776-780.
19. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond) 1995;88:551-556.
20. Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003;41:1264-1272. (Pubitemid 36438985)
21. Kim KS, Han HS, Hwang KK, Youn TJ, Kim DW, Cho MC, et al. The plasma level of N-terminal pro B-type natriuretic peptide (NT-proBNP) for severity of coronary artery stenosis and early risk stratification in patients with non ST elevation acute coronary syndrome. Korean Circ J 2004;34:133-141.
22. Sadanandan S, Cannon CP, Chekuri K, Murphy SA, Dibattiste PM, Morrow DA, et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2004;44:564-568. (Pubitemid 39078180)
23. Ambrose JA, Israel DH. Angiography in unstable angina. Am J Cardiol 1991;68:78B-84B.
24. Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B, et al. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol 2009;54:357-364.
25. War S, Squire IB, Downie PF, Mccullough AM, Campton MC, Davies JE, et al. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. Eur Heart J 2000;21:1514-1521.
26. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003;17:1105-1107.
27. Tóth M, Vuorinen KH, Vuolteenaho O, Hassinen IE, Uusimaa PA, Leppäluoto J, et al. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol 1994;266:H1572-H1580.
28. Tavi P, Laine M, Voutilainen S, Lehenkari P, Vuolteenaho O, Ruskoaho H, et al. Potentiation of stretch-induced atrial natriuretic peptide secretion by intracellular acidosis. Am J Physiol 1999;277:H405-H412. (Pubitemid 29354717)
29. Tunny TJ, Bachmann AW, Gordon RD. Response of atrial natriuretic peptide to adrenaline and noradrenaline infusion in man. Clin Exp Pharmacol Physiol 1988;15:299-303.
30. Angeja BG, De Lemos J, Murphy SA, Marble SJ, Antman EM, Cannon CP, et al. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. Am Heart J 2002;144:649-656.
31. Gibson CM. Has my patient achieved adequate myocardial reperfusion? Circulation 2003;108:504-507. (Pubitemid 36966118)
32. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998;55:1475-1482. (Pubitemid 28525511)
33. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996;93:1993-1999. (Pubitemid 26167228)
34. McIlroy DR, Wallace S, Roubos N. Brain natriuretic peptide (BNP) as a biomarker of myocardial ischemia-reperfusion injury in cardiac transplantation. J Cardiothorac Vasc Anesth 2010;24:939-945.